Piramal Group SWOT Analysis, USP & Competitors

Posted in Pharmaceuticals and Healthcare, Total Reads: 2121

SWOT Analysis of Piramal Group with USP, Competition, STP (Segmentation, Targeting, Positioning) - Marketing Analysis

Piramal Group

Parent Company

Piramal group


Retail stores


Lifestyle and Retail

Tagline/ Slogan

Knowledge action care


One of the most prominent pharma companies in India



Inidividuals and corporates seeking pharma products

Target Group

Middle class and upper class individuals


Quality and afforable pharmaceutical products

SWOT Analysis


1.Indian pharmaceutical and health care company with Piramal Enterprises is also one of the largest custom manufacturing companies across the World

2.High investment in R & D, Piramal Enterprises has a global R&D division in NY, a facility in India, and a manufacturing plant in Bethlehem

3.High Brand equity in healthcare industry

4. Piramal Healthcare is one of the fastest growing players by sales domestic consumer healthcare market, which deals with non-prescription products in the healthcare and wellness segment.

5. Good product portofolio and a strong workforce


1.Weak global presence compared to global players

2.Due to high competition brand has limited market share


1.Global presence by expansion

2. Healthcare sector is booming industry in coming years so expanding in this sector

3. Acquisition of smaller players to enhance image


1. Advanced technologies constantly demanding product innovation

2.Due to global slowdown people start spending less on healthcare expenses

3. Unfavorable govt policies



1.GlaxoSmithKline ltd


3.Ranbaxy laboratories

4. Biocon


Looking for More Brands? Search BrandGuide

Edit the Brand or Add a New One : Contribute to BrandGuide

The brandnames and other brand information used in the brandguide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only.
Utmost Care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.